Gender and age modify the association between APOE and AD-related neuropathology

Neurology

Volumn 56, Issue 12, 2001, Pages 1696-1701

  Ghebremedhin, Estifanos ^a   Schultz, C ^a   Thal, D R ^a   Rub U ^a   Ohm, T G ^b   Braak, E ^a   Braak, H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; FEMALE; GENDER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0035954324     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.12.1696     Document Type: Article

References (36)

1. Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the national institute on aging and the Reagan institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer disease
2. Frequency of stages of Alzheimer-related lesions in different age categories
3. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes
4. Neuropathological stageing of Alzheimer-related changes
5. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families
6. Apolipoprotein E polymorphism and Alzheimer's disease
7. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease
8. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
9. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
10. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
11. Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease
12. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease
13. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation
14. The apolipoprotein E ε4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant
15. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein
16. Association of apolipoprotein E ε4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease
17. Alzheimer pathology of patients carrying apolipoprotein E ε4 allele
18. Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians
19. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections
20. Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique
21. Apolipoprotein E genotyping by one-stage PCR
22. Improved method facilitates reliable APOE genotyping of genomic DNA extracted from formaldehyde-fixed pathology specimens
23. Argyrophilic grain disease is associated with apolipoprotein E ε2 allele
24. Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: Implications for Alzheimer's disease
25. Hypothesis: Microtuble instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype
26. High frequency of apolipoprotein E ε4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes
27. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging
28. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
29. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides
30. Estrogen upregulates Apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor α-mediated pathway
31. Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: Implications for Alzheimer's disease
32. Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction
33. Alzheimer disease: Interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset
34. Apolipoprotein E and cognitive change in an elderly population
35. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis
36. Epidemiology of clinically diagnosed Alzheimer's disease